NCM
PFE icon

Northwest Capital Management’s Pfizer PFE Stock Holding History

Northwest Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$2.55K – 191
2025
Q3 		$2.55K Hold
100
– – ﹤0.01% 229
2025
Q2 		$2.42K Sell
100
-1,323
-93% -$30.9K ﹤0.01% 317
2025
Q1 		$36.1K Buy
1,423
+1
+0.1% +$26 0.01% 213
2024
Q4 		$37.7K Hold
1,422
– – 0.02% 206
2024
Q3 		$41.2K Sell
1,422
-1
-0.1% -$29 0.01% 203
2024
Q2 		$39.8K Sell
1,423
-358
-20% -$9.86K 0.01% 197
2024
Q1 		$49.4K Hold
1,781
– – 0.02% 223
2023
Q4 		$51.3K Buy
1,781
+78
+5% +$2.36K 0.02% 219
2023
Q3 		$56.5K Sell
1,703
-27
-2% -$955 0.02% 199
2023
Q2 		$63.5K Buy
+1,730
New +$67.3K 0.03% 191
2022
Q4 		– Sell
-5,265
Closed -$230K – 97
2022
Q3 		$230K Buy
+5,265
New +$256K 0.13% 81

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northwest Capital Management's PFE Position: Q4 2025 in Review

Northwest Capital Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 100 shares — an estimated $2.55K sold.

Northwest Capital Management first reported a position in PFE in Q3 2022 and held it in 11 quarters. The position peaked at $230K in Q3 2022. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Northwest Capital Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Northwest Capital Management sold 100 Pfizer shares in Q4 2025, an estimated $2.55K.
  • Northwest Capital Management first reported a position in Pfizer in Q3 2022 and held it in 11 quarters.
  • Northwest Capital Management's Pfizer position peaked at $230K in Q3 2022.
  • 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Northwest Capital Management's 13F filing for Q4 2025, filed 26 Jan 2026.